{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:55:09Z","timestamp":1793404509559,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e26735","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T04:50:41Z","timestamp":1709182241000},"page":"e26735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Synthesis, anticancer activity and molecular docking of new quinolines, quinazolines and 1,2,4-triazoles with pyrido[2,3-d] pyrimidines"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8557-2806","authenticated-orcid":false,"given":"Ameen Ali","family":"Abu-Hashem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Amri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e26735_bib1","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1016\/j.bmcl.2013.04.009","article-title":"Discovery of pyrido[2,3-d] pyrimidine-based inhibitors of HCV NS5A","volume":"23","author":"DeGoey","year":"2013","journal-title":"Bioorg. Med. Chem. lett."},{"key":"10.1016\/j.heliyon.2024.e26735_bib2","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1002\/jhet.4109","article-title":"3D-Pharmacophore study molecular docking and synthesis of pyrido[2,3-d] pyrimidine-4(1H) dione derivatives with in vitro potential anticancer and antioxidant activities","volume":"57","author":"Gouda","year":"2020","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4103\/1735-5362.323912","article-title":"Synthesis, and cytotoxic evaluation of some novel 3-[2-(2-phenyl-thiazol-4-yl)-ethyl] -3H-pyrido [2,3-d] pyrimidin-4-one derivatives","volume":"16","author":"Khajouei","year":"2021","journal-title":"Res. Pharm Sci."},{"key":"10.1016\/j.heliyon.2024.e26735_bib4","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1021\/acsomega.8b01124","article-title":"Synthesis and antioxidant activity evaluation of some novel Aminocarbonitrile derivatives incorporating carbohydrate moieties","volume":"3","author":"Dangolani","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2024.e26735_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11696-019-00924-5","article-title":"In vitro Peripheral blood mononuclear cell proliferation, cytokine secretion and oxidative stress modulation by pyrido[2,3-d] pyrimidines","volume":"74","author":"Medjdoub","year":"2020","journal-title":"Chem. Pap."},{"key":"10.1016\/j.heliyon.2024.e26735_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jhet.4163","article-title":"Construction, characterization, and antimicrobial evaluation of the novel heteroannulated chromeno [2\u2032\u2032,3\u2032\u2032:6\u2032,5\u2032] pyrido[2\u2032,3\u2032-d] [1,3] thiazolo[3,2-a] pyrimidines","volume":"58","author":"Ibrahim","year":"2021","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04956","article-title":"Synthesis of arylidene hydrazinyl- pyrido[2,3-d] pyrimidin-4-ones as potent anti-microbial agents","volume":"6","author":"Abdelhameed","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e26735_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1134\/S1068162021020114","article-title":"Synthesis and biological activity studies of novel pyrido[2,3-d] pyrimidines and pyrido[2,3-d] triazines, russ","volume":"47","author":"Elsaedany","year":"2021","journal-title":"J. Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib9","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.bmcl.2009.05.044","article-title":"Synthesis of 4-substituted pyrido[2,3-d] pyrimidin-4(1H)-One as analgesic and anti-inflammatory agents","volume":"19","author":"El-Gazzar","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2024.e26735_bib10","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1080\/00397911.2020.1787449","article-title":"PEG-400 mediated an efficient eco-friendly synthesis of new isoxazolyl pyrido[2,3-d] pyrimidines and their anti-inflammatory and analgesic activity","volume":"50","author":"Dasari","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.heliyon.2024.e26735_bib11","first-page":"1171","article-title":"PEG-400 promoted a simple, efficient and eco-friendly synthesis of functionalized novel isoxazolyl pyrido[2,3-d] pyrimidines and their antimicrobial and anti-inflammatory activity","volume":"51","author":"Rani","year":"2021","journal-title":"Synth. Commun."},{"key":"10.1016\/j.heliyon.2024.e26735_bib12","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/j.bmcl.2011.03.045","article-title":"A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity","volume":"21","author":"Rajesh","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2024.e26735_bib13","first-page":"2929","article-title":"Synthesis of 2,4-diamino-6 (Thioarylmethyl)Pyrido [2,3-d] pyrimidines as dihydrofolate reductase inhibitors, bioorg","volume":"9","author":"Gangjee","year":"2001","journal-title":"Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejmech.2017.01.033","article-title":"Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido [3,2-d] pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase","volume":"128","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.carres.2013.07.008","article-title":"Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic \u03b1-glucosidase inhibitors","volume":"380","author":"Panahi","year":"2013","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.heliyon.2024.e26735_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejmech.2018.05.046","article-title":"New 6-amino-pyrido[2,3-d] pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: a simple and efficient synthesis, \u03b1-glucosidase inhibition, molecular modeling, and kinetic study","volume":"155","author":"Adib","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113023","article-title":"Pyrido [2, 3-d] pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors","volume":"211","author":"Huang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib18","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/S0960-894X(03)00642-5","article-title":"Adenosine kinase inhibitors: polar 7-Substituents of pyridopyrimidine derivatives improving their locomotor selectivity","volume":"13","author":"Zheng","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2024.e26735_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/molecules27030835","article-title":"Design, synthesis of new 1, 2, 4-triazole\/1, 3, 4-thiadiazole with spiroindoline, imidazo [4, 5-b] quinoxaline and Thieno [2, 3-d] pyrimidine from isatin derivatives as anticancer agents","volume":"27","author":"Abu-Hashem","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e26735_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2174\/1570180817666200117114716","article-title":"Design, synthesis, and anticancer potential of the enzyme (PARP-1) inhibitor with computational studies of new triazole, thiazolidinone, -Thieno [2, 3-d] pyrimidinones","volume":"17","author":"Abu-Hashem","year":"2020","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.heliyon.2024.e26735_bib21","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/molecules26072031","article-title":"Design, synthesis and anticancer activity of new polycyclic: imidazole, thiazine, oxathiine, pyrrolo-quinoxaline and thienotriazolopyrimidine derivatives","volume":"26","author":"Abu-Hashem","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e26735_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2478\/v10007-010-0027-6","article-title":"Design and synthesis of novel thiophenecarbohydrazide, thienopyrazole and thienopyrimidine derivatives as antioxidant and antitumor agents","volume":"60","author":"Abu-Hashem","year":"2010","journal-title":"Acta Pharm."},{"key":"10.1016\/j.heliyon.2024.e26735_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jccs.201400351","article-title":"Design, synthesis of novel thiourea and pyrimidine derivatives as potential antitumor agents","volume":"62","author":"Abu-Hashem","year":"2015","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.heliyon.2024.e26735_bib24","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00706-017-1960-6","article-title":"Synthesis of new quinoxaline, pyrimidine, and pyrazole furochromone derivatives as cytotoxic agents","volume":"148","author":"Abu-Hashem","year":"2017","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.31788\/RJC.2021.1426137","article-title":"Synthesis, structural characterization of some pyrazolo [1-5a] pyrimidine and imidazo[1,2-b] pyrazole derivatives as anti-cancer activity","volume":"14","author":"Fathy","year":"2021","journal-title":"Rasayan J. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1570180812666150429234237","article-title":"Synthesis and antitumor activity of new pyrimidine and caffeine derivatives","volume":"12","author":"Abu-Hashem","year":"2015","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.heliyon.2024.e26735_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jccs.201190056","article-title":"Synthesis, antioxidant, antitumor activities of some new thiazolo pyrimidines, pyrrolothiazolopyrimidines and triazolo-pyrrolothiazolo pyrimidines derivatives","volume":"58","author":"Abu-Hashem","year":"2011","journal-title":"J. Chinese. Chemical Society"},{"key":"10.1016\/j.heliyon.2024.e26735_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ejmech.2008.03.022","article-title":"Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti- inflammatory and analgesic activities","volume":"44","author":"El-Gazzar","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12272-012-0306-5","article-title":"Synthesis of new pyrazole, triazole, thiazolidine, -Pyrimido[4,5-b] quinoline derivatives with potential antitumor activity","volume":"35","author":"Abu-Hashem","year":"2012","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.heliyon.2024.e26735_bib30","first-page":"379","article-title":"Synthesis and antioxidant, anti-inflammatory and analgesic activity of novel polycyclic pyrimido[4,5-b] quinolines, phosphorus sulfur silicon relat","volume":"184","author":"El-Gazzar","year":"2009","journal-title":"Elem"},{"key":"10.1016\/j.heliyon.2024.e26735_bib31","first-page":"2009","article-title":"Synthesis and antioxidant activity of novel pyrimido[4,5-b] quinolin-4-one derivatives with a new ring system, phosphorus sulfur silicon relat","volume":"182","author":"El-Gazzar","year":"2007","journal-title":"Elem"},{"issue":"29","key":"10.1016\/j.heliyon.2024.e26735_bib32","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2174\/1570178617666200417121205","article-title":"Recent development in the chemistry of bicyclic 6+5 systems, Part II: chemistry of triazolopyrimidine derivatives","volume":"17","author":"Gouda","year":"2020","journal-title":"Lett. Org. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.poly.2011.11.020","article-title":"Structural consequences of the introduction of 2,20-bipyrimidine as auxiliary ligand in triazolopyrimidine-based transition metal complexes. In vitro antiparasitic activity","volume":"33","author":"Caballero","year":"2012","journal-title":"Polyhedron"},{"key":"10.1016\/j.heliyon.2024.e26735_bib34","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.ejmech.2008.09.031","article-title":"Acyclic nucleoside bisphosphonates: synthesis and properties of chiral 2-amino-4,6-bis[(phosphono-methoxy) alkoxy] pyrimidines","volume":"44","author":"Dol\u00e1kov\u00e1","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00044-016-1733-5","article-title":"Synthesis of novel 1, 2, 4-triazolo- pyrimidines and their evaluation as antimicrobial agents","volume":"26","author":"Abu-Hashem","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.heliyon.2024.e26735_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/jhet.2645","article-title":"Synthesis and antimicrobial activity of some novel quinoline, chromene, pyrazole derivatives bearing triazolopyrimidine moiety","volume":"54","author":"Abu-Hashem","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2174\/1573406416666200406130047","article-title":"Synthesis and antimicrobial activity of novel 1, 2, 4-Triazolopyrimidofuro-quinazolinones from natural furochromones (visnagenone and khellinone)","volume":"17","author":"Abu-Hashem","year":"2021","journal-title":"Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib38","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1158\/0008-5472.CAN-07-1420","article-title":"TTI-237: a novel microtubule-active compound with in vivo antitumor activity","volume":"68","author":"Beyer","year":"2008","journal-title":"J. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e26735_bib39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hc.10166","article-title":"Polyfunctional fused heterocyclic compounds via indene-1,3-diones","volume":"14","author":"Hassaneen","year":"2003","journal-title":"Heteroatom Chem"},{"key":"10.1016\/j.heliyon.2024.e26735_bib40","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/81200910","article-title":"2-Arylhydrazonopropanals as building blocks in heterocyclic chemistry: microwave assisted condensation of 2-Aryl-hydrazono-propanals with amines and active methylene reagents","volume":"8","author":"Al-Zaydi","year":"2003","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e26735_bib41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1248\/cpb.39.1099","article-title":"A reagent, ethyl 2-(2-tert-Butyl-2H-tetrazol-5-yl)-3-(dimethylamino) acrylate (DMTE), for facile synthesis of 2, 3-(ring fused)-5-(5-tetratzolyl)-4H-pyrimidin-4-one derivatives","volume":"39","author":"Kanno","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2024.e26735_bib42","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1016\/j.ejmech.2009.07.013","article-title":"Analgesic, anticonvulsant, and anti-inflammatory activities of some synthesized benzodiazipine, triazolopyrimidine and bis-imide derivatives","volume":"44","author":"Said","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cmdc.201500218","article-title":"Novel triazolopyrimidine-derived cannabinoid receptor 2 agonists as potential treatment for inflammatory kidney diseases","volume":"11","author":"Nettekoven","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.heliyon.2024.e26735_bib44","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/jm8014537","article-title":"Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor","volume":"52","author":"Li","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1521-4184(200208)335:6<289::AID-ARDP289>3.0.CO;2-Z","article-title":"Pyrido [2, 3-d] pyrimidines and pyrimido [5',4':5,6] pyrido [2,3-d] pyrimidines as new antiviral agents: synthesis and biological activity","volume":"335","author":"Nasr","year":"2002","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.heliyon.2024.e26735_bib46","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1023\/A:1012498322793","article-title":"Fluoro-containing heterocycles: V. Cyclization of 3-Azolylamino-2-polyfluoro- benzoylacrylates","volume":"37","author":"Lipunova","year":"2001","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib47","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1016\/j.bmc.2009.10.012","article-title":"Synthesis, tautomerism, and antimicrobial, anti-HCV, anti-SSPE, antioxidant, and antitumor activities of arylazobenzosuberones","volume":"17","author":"Farghaly","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib48","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ejmech.2008.09.030","article-title":"New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, antioxidant and anti-microbial derived from pyrimido [4,5-b] quinolines","volume":"44","author":"El-Gazzar","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib49","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ejmech.2009.11.050","article-title":"El-AzizNew pyrazoles incorporating pyrazolyl- pyrazole moiety: synthesis, anti-HCV, and antitumor activity","volume":"45","author":"Riyadh","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejmech.2009.10.033","article-title":"Synthesis, anti-HCV, antioxidant, and peroxynitrite inhibitory activity of fused benzosuberone derivatives","volume":"45","author":"Farghaly","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.aihch.2018.10.002","article-title":"Chapter one: recent advances in 1,2,4-triazolo[1,5-a] pyrimidine","volume":"128","author":"Fischer","year":"2019","journal-title":"Adv. Heterocycl. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib52","doi-asserted-by":"crossref","first-page":"65496","DOI":"10.1039\/C5RA08778C","article-title":"Antihypertensive activity of a quinoline appended chalcone derivative and its site-specific binding interaction with a relevant target carrier protein","volume":"5","author":"Kumar","year":"2015","journal-title":"RSC adv"},{"key":"10.1016\/j.heliyon.2024.e26735_bib53","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.4314\/tjpr.v17i9.25","article-title":"Synthesis of new quinoline scaffolds via a solvent-free fusion method and their anti-microbial properties","volume":"17","author":"Mubeen","year":"2018","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.heliyon.2024.e26735_bib54","first-page":"1","article-title":"Synthesis, design, and antimicrobial activity of pyrido[2,3-d] [1,2,4] triazolo[4,3-a] pyrimidinones based on quinoline derivatives","author":"Abu-Hashem","year":"2023","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.heliyon.2024.e26735_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115511","article-title":"Cytotoxicity of 4-substituted quinoline derivatives: anticancer and antileishmanial potential","volume":"28","author":"Costa","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1039\/D0MD00244E","article-title":"Medicinal chemistry updates on quinoline- and endoperoxide-based hybrids with potent antimalarial activity","volume":"12","author":"Uddin","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128305","article-title":"Azoimine quinoline derivatives: synthesis, classical and electrochemical evaluation of antioxidant, anti-inflammatory, antimicrobial activities and the DNA\/BSA binding","volume":"1217","author":"Douadi","year":"2020","journal-title":"J. Mol. Stru."},{"key":"10.1016\/j.heliyon.2024.e26735_bib58","doi-asserted-by":"crossref","first-page":"31139","DOI":"10.1039\/D0RA05594H","article-title":"Molecular targets and anticancer activity of quinoline\u2013chalcone hybrids: literature review","volume":"10","author":"Mohamed","year":"2020","journal-title":"RSC adv"},{"key":"10.1016\/j.heliyon.2024.e26735_bib59","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1007\/s00044-014-1048-3","article-title":"Pharmacophore modeling, 3DQSAR, and docking-based design of polysubstituted quinolines derivatives as inhibitors of phosphodiesterase 4, and preliminary evaluation of their anti-asthmatic potential","volume":"23","author":"Gaurav","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.heliyon.2024.e26735_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113208","article-title":"Synthesis, and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents","volume":"214","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmech.2012.07.029","article-title":"Design, synthesis, antimicrobial, anti-inflammatory and analgesic activity of novel isoxazolyl pyrimido[4,5-b] quinolines and isoxazolyl chromeno[2,3-d] pyrimidin-4-ones","volume":"55","author":"Rajanarendar","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib62","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1021\/acs.jnatprod.8b00036","article-title":"In vitro mechanistic study of the anti-inflammatory activity of a quinoline isolated from spondias pinnata bark","volume":"81","author":"Ghate","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.heliyon.2024.e26735_bib63","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1016\/j.bmcl.2017.07.033","article-title":"Design, synthesis, and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid","volume":"27","author":"Gu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2024.e26735_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1573406413666171002121817","article-title":"Quinoline fluorescent probes for zinc \u2013 from diagnostic to therapeutic molecules in treating neurodegenerative diseases","volume":"14","author":"Czaplinska","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib65","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/jhet.5570290435","article-title":"Synthesis of some novel azido\/tetrazolothienopyrimidines and their reduction to 2,4-diaminothieno[2,3-d] pyrimidines","volume":"29","author":"Shishoo","year":"1992","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"Immunol Methods"},{"key":"10.1016\/j.heliyon.2024.e26735_bib67","first-page":"394","article-title":"Synthesis of novel 1,6-naphthyridines, pyrano[3,2-c] pyridines and pyrido[4,3-d] pyrimidines derived from 2,2,6,6-tetramethyl-piperidin-4-one for in vitro anticancer and antioxidant evaluation","volume":"6","author":"Soliman","year":"2014","journal-title":"Der Pharma Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib68","first-page":"987","article-title":"Synthesis, tumor inhibitory and antioxidant activity of new polyfunctionally 2-substituted 5, 6, 7, 8-tetrahydro- naphthalene derivatives containing pyridine, thioxopyridine and pyrazolopyridine moieties","volume":"70","author":"Hamdy","year":"2013","journal-title":"Acta Pol Pharm - Drug Res."},{"key":"10.1016\/j.heliyon.2024.e26735_bib69","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1007\/s00044-012-0272-y","article-title":"Synthesis and antitumor screening of new series of pyrimido-[4,5-b]quinolines and [1,2,4]triazolo[2\u2032,3\u2032:3,4]pyrimido [6,5-b]quinolines","volume":"22","author":"El-Ashmawy","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.heliyon.2024.e26735_bib70","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1158\/0008-5472.CAN-07-1420","article-title":"TTI-237: a novel microtubule-active compound with In vivo antitumor activity","volume":"68","author":"Beyer","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e26735_bib71","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/jm8014537","article-title":"Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethyl-pyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl) meth- yl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor","volume":"52","author":"Li","year":"2009","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e26735_bib72","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"Auto Dock Vina 1.2. 0: new docking methods expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e26735_bib73","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"issue":"48","key":"10.1016\/j.heliyon.2024.e26735_bib74","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e26735_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abd2508","article-title":"Metachronal patterns in artificial cilia for low Reynolds number fluid propulsion","volume":"6","author":"Milana","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26735_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"Swiss ADME: a free web tool to evaluate pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26735_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26735_bib78","article-title":"8-benzimidazolyl coumarin 3-oxadiazoles \u2013 synthesis, docking studies and Anti-proliferative evaluation against breast cancer","volume":"1294","author":"Patagar","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e26735_bib79","article-title":"Synthesis, antioxidant, and anti-diabetic potential of novel benzimidazole substituted coumarin-3-carboxamides","volume":"1274","author":"Patagar","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e26735_bib80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11164-016-2633-5","article-title":"Synthesis and anticancer activity of novel 2-substituted pyranopyridine derivatives","volume":"43","author":"Mohamed","year":"2017","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.heliyon.2024.e26735_bib81","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/molecules22010170","article-title":"Synthesis and anticancer activity of new 1-thia-4-azaspiro [4.5] decane, their derived thiazolo- pyrimidine and 1, 3, 4-thiadiazole thioglycosides","volume":"22","author":"Flefel","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e26735_bib82","first-page":"388","article-title":"Synthesis, and antitumor activity of some new pyrazolo [1, 5-a] pyrimidines, Chin","volume":"28","author":"Hassan","year":"2017","journal-title":"Chem. Lett."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402402766X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402402766X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:22:25Z","timestamp":1769044945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402402766X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S240584402402766X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26735","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, anticancer activity and molecular docking of new quinolines, quinazolines and 1,2,4-triazoles with pyrido[2,3-d] pyrimidines","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26735"}}